Cargando…

CD73 facilitates invadopodia formation and boosts malignancy of head and neck squamous cell carcinoma via the MAPK signaling pathway

Elevated adenosine generated by CD73 (ecto‐5′‐nucleotidase; NT5E) could boost immunosuppressive responses and promote immune evasion in the tumor microenvironment. However, despite the immune response, CD73 could also promote tumor progression in a variety of cancers, and the nonimmunologic role and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Feifei, Wang, Tianxiao, Shi, Hao, Feng, Hongjie, Feng, Guanying, Wang, Ruixia, Yao, Yao, Yuan, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357645/ https://www.ncbi.nlm.nih.gov/pubmed/35657703 http://dx.doi.org/10.1111/cas.15452

Ejemplares similares

The Identification of Stemness-Related Genes in the Risk of Head and Neck Squamous Cell Carcinoma
por: Feng, Guanying, et al.
Publicado: (2021)

Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR‐421 and E‐cadherin
por: Ji, Yefeng, et al.
Publicado: (2020)

CLPTM1L Is a Novel Putative Oncogene Promoting Tumorigenesis in Oral Squamous Cell Carcinoma
por: Hou, Yunwen, et al.
Publicado: (2021)

Data on the effects of ECM rigidity on actomyosin contractility and invadopodia activity in individual versus pairs of head and neck squamous cell carcinoma cells
por: Jerrell, Rachel, et al.
Publicado: (2021)

Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma
por: Chen, Yuming
Publicado: (2022)

Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma
por: He, Yingzheng, et al.
Publicado: (2020)

Invadopodia in context
por: Bergman, Aviv, et al.
Publicado: (2014)

Argyrophilic nuclear organizer region and p73 expression in head and neck squamous cell carcinomas: Teammates or adversaries?
por: Venkateswaran, Sunil Pazhayanur, et al.
Publicado: (2016)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Cortactin function in invadopodia
por: Jeannot, Pauline, et al.
Publicado: (2017)

Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV‐positive head and neck squamous cell carcinoma cells
por: Kahue, Charissa N., et al.
Publicado: (2018)

CD73 expression in myeloid-derived suppressor cells is correlated with clinical stages in head and neck squamous cell carcinomas
por: Zheng, Weihui, et al.
Publicado: (2021)

High-dose stereotactic radiotherapy boost in the treatment of squamous cell carcinoma of the head and neck region
por: Polanowski, Paweł, et al.
Publicado: (2022)

Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma
por: Gong, Wang, et al.
Publicado: (2016)

Erlotinib sensitivity of MAPK1p.D321N mutation in head and neck squamous cell carcinoma
por: Ngan, Hoi-Lam, et al.
Publicado: (2020)

Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability
por: Martín-Villar, E, et al.
Publicado: (2015)

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Wang, Hui-Ching, et al.
Publicado: (2019)

Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma
por: Wang, Lei, et al.
Publicado: (2022)

Characteristics of esophageal cancer in patients with head and neck squamous cell carcinoma
por: Wang, Lei, et al.
Publicado: (2021)

Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy: A New Weapon for Squamous Cell Carcinoma of the Head and Neck?
por: Longo, Francesco, et al.
Publicado: (2020)

Precision drugging of the MAPK pathway in head and neck cancer
por: Ngan, Hoi-Lam, et al.
Publicado: (2022)

Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma
por: Yao, Yao, et al.
Publicado: (2020)

The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma
por: Zhong, Feng, et al.
Publicado: (2020)

Malignant and Nonmalignant Gene Signatures in Squamous Head and Neck Cancer
por: Worsham, Maria J., et al.
Publicado: (2012)

Inhibition of invadopodia formation by diosgenin in tumor cells
por: Lian, Yaxin, et al.
Publicado: (2020)

Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma
por: Shen, Ao, et al.
Publicado: (2022)

Dense collagen kindles invadopodia formation
por: Short, Ben
Publicado: (2015)

Tumour: Fibroblast Interactions Promote Invadopodia-Mediated Migration and Invasion in Oral Squamous Cell Carcinoma
por: Kato, Koroku, et al.
Publicado: (2022)

Ubiquitous membrane-bound DNase activity in podosomes and invadopodia
por: Pal, Kaushik, et al.
Publicado: (2021)

A comparison of clinical outcomes between simultaneous integrated boost (SIB) versus sequential boost (SEQ) intensity modulated radiation therapy (IMRT) for head and neck cancer: A meta-analysis
por: Jiang, Li, et al.
Publicado: (2019)

An Epithelial–Mesenchymal Transition Hallmark Gene-Based Risk Score System in Head and Neck Squamous-Cell Carcinoma
por: Liang, Feifei, et al.
Publicado: (2021)

Transcriptomic study of the mechanism of anoikis resistance in head and neck squamous carcinoma
por: Guo, Chen, et al.
Publicado: (2019)

Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma
por: Zhou, Shichao, et al.
Publicado: (2021)

circ_0000045 promotes proliferation, migration, and invasion of head and neck squamous cell carcinomas via regulating HSP70 and MAPK pathway
por: Sun, Ronghao, et al.
Publicado: (2022)

Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma
por: Meng, Di, et al.
Publicado: (2021)

Stromal fibroblasts facilitate cancer cell invasion by a novel invadopodia-independent matrix degradation process
por: Cao, Hong, et al.
Publicado: (2015)

Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas
por: Hsu, Cheng-Ming, et al.
Publicado: (2021)

6-shogaol is a potential treatment for Head and Neck Squamous Cell Carcinoma
por: Hsu, Cheng-Ming, et al.
Publicado: (2023)

MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma
por: Bonnin, Nathalie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4pij8g4stj42fme94n9a64nbjg